| Tag | Content |
|---|
EnhancerAtlas ID | HS109-12766 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:128147300-128147950 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| SPI1 | MA0080.4 | chr2:128147888-128147902 | AACTTCCTCTTTTG | - | 6.89 | | SPIC | MA0687.1 | chr2:128147888-128147902 | AACTTCCTCTTTTG | - | 6.45 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_09644 | chr2:128141853-128148952 | CD14 | | SE_10675 | chr2:128144112-128148979 | CD19_Primary | | SE_11490 | chr2:128143043-128150313 | CD20 | | SE_29146 | chr2:128143818-128147607 | Fetal_Intestine_Large | | SE_50833 | chr2:128147222-128147931 | Sigmoid_Colon | | SE_54354 | chr2:128146998-128148044 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TGCAGTGATA AAATTATATA GTCCCCACTG CCCAGGAACT CAGAATCCTG TGAGGAAGGC 60
AGACAGGTAA ATGGATAATG ATAACACACT GTGACCTGCA TCATGGGAGG GATGTGTATC 120
AGGCACCACA GCAGCAAGAG GAAGATGTCA CAGGTGTGTC TGGGGAAGTG AGAGATGACT 180
TCAGAGAGGA AATGTGGCAT GTTCCTTTTC TGTTGCTGCA TAACAAACTG CCACAAACTT 240
AGTGACTTAA AACAGTGTCT GTTTTTTAGC TCCCAGTTAT ACAGATCAGA AGTTTGCACA 300
GGGGCAAGGC TGAGTTCTCT ACTCAGGGTA TATTGCAAGG CTGAAATCAA GGTATCAGCT 360
GGGCTGACTT TTTATCTAGA GGCCCTTGCA AAGATCTTCC AAGCTCATTC TTCTTTGGGG 420
CACAATTCAG TTTCCTGTGG TTGTAGGATT GACATCCCTA TTTCCTGGGC CTGCCTTCAG 480
TTCCTAGAGG TCACCTGCAT TCCTTGCCAC ATGACCCCTT CCATCTTGAA AGCCAGCGAC 540
AGAGACCTTC TTGCGTGCCA AACATCCTCC TACATCAGAT CTCTCTCTAA CTTCCTCTTT 600
TGCTACCAGC CAGAGAAAAC TCTCTGCTTT TATTTTTATT TATTTTTTTA 650
|
